INO 241220 3.50P (INO241220P3500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

INO241220P3500

Watchlist

1.25
+1.19+1983.33%

15min DelayClose Dec 13 16:00 ET

1.55High0.83Low

Intraday

5D
Daily

News

Comments

Aron40

Dec 13 08:10

$Inovio Pharmaceuticals (INO.US)$
i have some shares. with this under writing, is it better to hold or sell off?

Trytosaveabit

Dec 13 06:05

$Inovio Pharmaceuticals (INO.US)$ Inovio Pharmaceuticals Priced An Underwritten Public Offering Of 10M Shares And Accompanying Warrants To Purchase 10M Shares At An Exercise Price Of $3.76/Share, At A Combined Public Offering Price Of $3/Share And Accompanying Warrant, With Gross Proceeds Of $30M

Trytosaveabit

Dec 3 07:02

Update

$Inovio Pharmaceuticals (INO.US)$ Reuters· 1 min ago
New Retrospective Data Shows Half of Rrp Patients Treated With Ino-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

Jaguar8

Oct 21 21:27

Put alert. PR today on data re HPV. Will present tomorrow full efficacy and safety data. SI 14%.

$Inovio Pharmaceuticals (INO.US)$

Trytosaveabit

Oct 21 07:02

Update

$Inovio Pharmaceuticals (INO.US)$ Reuters· 1 min ago
Inovio Announces New Data at Scientific Conferences for Lead Candidate, Ino-3107, as a Potential Treatment for Rrp